カテゴリ： GlobalData, アメリカ, 企業調査

Neurosigma Inc：企業の製品パイプライン分析2018

◆英語タイトル：Neurosigma Inc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12200
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stress disorders. It also conducts preclinical research and development, and phase clinical trials. The company trigeminal nerve stimulation has been investigated as a therapy for epilepsy, depression, attention deficity hyperactivity disorder, and post-traumatic stress disorder, Lennox-Gastaut syndrome and traumatic brain injuries, among others. NeuroSigma is headquartered in Los Angeles, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Neurosigma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Neurosigma Inc Company Overview 5
Neurosigma Inc Company Snapshot 5
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Neurosigma Inc – Pipeline Analysis Overview 8
Neurosigma Inc – Key Facts 8
Neurosigma Inc – Major Products and Services 9
Neurosigma Inc Pipeline Products by Development Stage 10
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12
Neurosigma Inc Pipeline Products Overview 14
Deep Brain Stimulation System – Cachexia 14
Deep Brain Stimulation System – Cachexia Product Overview 14
Deep Brain Stimulation System – Obesity 15
Deep Brain Stimulation System – Obesity Product Overview 15
Flow-Diverting TFN Stent 16
Flow-Diverting TFN Stent Product Overview 16
Micropatterned TFN Stent 17
Micropatterned TFN Stent Product Overview 17
Monarch eTNS System – ADHD 18
Monarch eTNS System – ADHD Product Overview 18
Monarch eTNS System – ADHD Clinical Trial 19
Monarch eTNS System – Depression 20
Monarch eTNS System – Depression Product Overview 20
Monarch eTNS System – Depression Clinical Trial 21
Monarch eTNS System – Epilepsy 22
Monarch eTNS System – Epilepsy Product Overview 22
Monarch eTNS System – Epilepsy Clinical Trial 23
Monarch eTNS System – Lennox-Gastaut Syndrome 24
Monarch eTNS System – Lennox-Gastaut Syndrome Product Overview 24
Monarch eTNS System – Post-Traumatic Stress Disorder 25
Monarch eTNS System – Post-Traumatic Stress Disorder Product Overview 25
Monarch eTNS System – Traumatic Brain Injury 26
Monarch eTNS System – Traumatic Brain Injury Product Overview 26
sTNS System – Epilepsy 27
sTNS System – Epilepsy Product Overview 27
Thin Film Nitinol Flow Diverting Stent 28
Thin Film Nitinol Flow Diverting Stent Product Overview 28
Neurosigma Inc – Key Competitors 29
Neurosigma Inc – Key Employees 30
Neurosigma Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Neurosigma Inc, Recent Developments 32
Oct 30, 2017: UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma’s Non-Invasive eTNS System for Treatment of Pediatric ADHD 32
Jan 28, 2016: Electric patch holds promise for treating PTSD 33
Dec 10, 2015: Preliminary Results Utilizing NeuroSigma’s Monarch eTNS System for the Treatment of Traumatic Brain Injury Presented at the North American Neuromodulation Society Annual Meeting 34
Nov 16, 2015: NeuroSigma’s Monarch eTNS System Receives CE Mark Approval for ADHD 34
May 04, 2015: NeuroSigma’s Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 35
Jan 06, 2015: FDA Grants NeuroSigma Humanitarian Use Device (HUD) Designation 35
Jan 05, 2015: UCLA Launches Phase II Pediatric Clinical Trial for the Treatment of ADHD with NeuroSigma’s eTNS System 36
Nov 19, 2014: NeuroSigma Congratulates Brazilian Medical Team for Their Top-Line Results in Phase II Clinical Trial of eTNS for Treatment of Depression 37
Nov 17, 2014: NeuroSigma Announces Top-Line Findings of UCLA Phase II Clinical Trial of eTNS for the Treatment of Depression 38
Nov 03, 2014: NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation 38
Appendix 40
Methodology 40
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Neurosigma Inc Pipeline Products by Equipment Type 6
Neurosigma Inc Pipeline Products by Indication 7
Neurosigma Inc Ongoing Clinical Trials by Trial Status 7
Neurosigma Inc, Key Facts 8
Neurosigma Inc, Major Products and Services 9
Neurosigma Inc Number of Pipeline Products by Development Stage 10
Neurosigma Inc Pipeline Products Summary by Development Stage 11
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12
Neurosigma Inc Ongoing Clinical Trials Summary 13
Deep Brain Stimulation System - Cachexia - Product Status 14
Deep Brain Stimulation System - Cachexia - Product Description 14
Deep Brain Stimulation System - Obesity - Product Status 15
Deep Brain Stimulation System - Obesity - Product Description 15
Flow-Diverting TFN Stent - Product Status 16
Flow-Diverting TFN Stent - Product Description 16
Micropatterned TFN Stent - Product Status 17
Micropatterned TFN Stent - Product Description 17
Monarch eTNS System - ADHD - Product Status 18
Monarch eTNS System - ADHD - Product Description 18
Monarch eTNS System - ADHD - Developmental Pilot Study of External Trigeminal Nerve Stimulation for ADHD 19
Monarch eTNS System - Depression - Product Status 20
Monarch eTNS System - Depression - Product Description 20
Monarch eTNS System - Depression - Effect of TNS for Major Depressive Disorder in the Elderly: A Phase II Randomized Controlled Trial 21
Monarch eTNS System - Depression - External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Depression 21
Monarch eTNS System - Depression - Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: A Phase II, Randomized, Double-blind Clinical Trial 21
Monarch eTNS System - Epilepsy - Product Status 22
Monarch eTNS System - Epilepsy - Product Description 22
Monarch eTNS System - Epilepsy - Evaluation of the Monarch eTNS Therapy for Neurological and Neuropsychiatric Disorders in Pediatrics 23
Monarch eTNS System - Epilepsy - External Trigeminal Nerve Stimulation for Epilepsy 23
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Status 24
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Description 24
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Status 25
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Description 25
Monarch eTNS System - Traumatic Brain Injury - Product Status 26
Monarch eTNS System - Traumatic Brain Injury - Product Description 26
sTNS System - Epilepsy - Product Status 27
sTNS System - Epilepsy - Product Description 27
Thin Film Nitinol Flow Diverting Stent - Product Status 28
Thin Film Nitinol Flow Diverting Stent - Product Description 28
Neurosigma Inc, Key Employees 30
Neurosigma Inc, Subsidiaries 31
Glossary 42

List of Figures
Neurosigma Inc Pipeline Products by Equipment Type 6
Neurosigma Inc Pipeline Products by Development Stage 10
Neurosigma Inc Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[Neurosigma Inc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • MolMed SpA (MLM)：企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Provence Technologies SAS-製薬・医療分野：企業M&A・提携分析
    Summary Provence Technologies SAS (ProvenceTech) is a contract research organization that provides fine organic chemistry solutions. The organization’s services include chemical development, analytical development and, global offer and consulting. It also provides research and development services. …
  • Kolon Life Science Inc (102940)：製薬・医療：M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Kuwait Petroleum International Ltd：企業の戦略的SWOT分析
    Kuwait Petroleum International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Beam Suntory Inc.：企業の戦略・SWOT・財務分析
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TOA Corporation：企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • APIM Therapeutics AS-製薬・医療分野：企業M&A・提携分析
    Summary APIM Therapeutics AS (APIM) is a drug development company that offers novel anti-cancer therapies. The company offers development of peptide compounds such as mitomycin-c, cisplatin, melphatan, ATX compounds, cytarabine, cisplatin, docetaxel and temozolomide. Its compounds are used in indica …
  • Putzmeister Holding GmbH：企業の戦略・SWOT・財務分析
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Orange Belgium (OBEL)：企業の戦略的SWOT分析
    Orange Belgium (OBEL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CeraPedics Inc-医療機器分野：企業M&A・提携分析
    Summary CeraPedics Inc (Cerapedics) is a provider of osteobiologic treatment solutions. The company’s products include i-factor putty and i-factor flex. Its i-factor putty is a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to …
  • The Brink’s Company：企業の戦略・SWOT・財務分析
    The Brink's Company - Strategy, SWOT and Corporate Finance Report Summary The Brink's Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bri-Chem Corp. (BRY)：石油・ガス：M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • 2020 GeneSystems Inc：医療機器：M&Aディール及び事業提携情報
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of l …
  • Natera Inc (NTRA)：企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Sino Hotels (Holdings) Limited：企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Retail Food Group Limited (Foodservice)：企業の戦略・SWOT・財務情報
    Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Retail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Mehler Vario System GmbH：企業の戦略・SWOT・財務情報
    Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report Summary Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oil States Industries Inc：石油・ガス：M&Aディール及び事業提携情報
    Summary Oil States Industries Inc (Oil States), a subsidiary of Oil States International Inc, is a provider of intergrated energy systems and solutions that offers oil and gas products and services. The company provides products in the areas of offshore, onshore, marine and industrial areas, among o …
  • SHI International Corp.：企業の戦略的SWOT分析
    SHI International Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Owens & Minor Inc (OMI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and su …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆